Another surprise from GLP-1s - 53% reduction in risk to develop pancreatic cancer in diabetes patients
acg2024.eventscribe.net/fsPopup.asp?...
#OncoSky #GLP1s #pancreaticcancer

For anyone who missed #ACG2024!

Intragastric Balloon (IGB) vs. Endoscopic Sleeve Gastroplasty (ESG) for weight loss

📍 ESG potentially achieves more durable weight loss with less side effects.

🔗 journals.lww.com/ajg/fulltext...

#GISky #EndoscopySky #GastroSky
@amcollegegastro.bsky.social

Grateful to have had the opportunity to attend #ACG2024! Thrilled to collaborate with @ownyourcrohns.bsky.social & @crohnsbabble.bsky.social to capture our key takeaways for @southasianibd.bsky.social / @ibdesis.bsky.social! 🙌🏽

The risk of #PancreaticCancer for people with #diabetes who receive a #GLP1 is half of what it is for others. Too good to be true? Or too good to dismiss? Outstanding new research at #ACG2024.
conscienhealth.org/2024/11/a-ha...

NEW #OnTheBlog Our Patient Experience at #ACG2024 ✍🏽

This #CCAwarenessWeek, it’s important for us to share & spread the love of all that we learned at ACG (@amcollegegastro.bsky.social)

Check out our blog post here: southasianibd.org/patient-expe...

Eine weitere US-amerikanische Registerstudie wurde beim ACG vorgestellt aber noch nicht veröffentlicht.
Hier wurde sogar eine signifikante Reduktion des Pankreaskarzinomrisikos beobachtet.
#FOAMed

acg2024.eventscribe.net/fsPopup.asp?...

This phase 3 trial presented at #ACG2024 found semaglutide effective for treating #MASH. The results were a “highlight of the meeting" and a "watershed moment in the MASH field."

During #ACG2024, #SAIA hosted an insightful panel featuring Dr. Bincy Abraham on the growing role of #IntestinalUltrasound (IUS) in #IBD care 🙌🏽

Click below to watch the video for expert insights on how #IUS can improve patient acceptance & uptake of therapies 🙏🏽

🎥 www.instagram.com/reel/DFLA5Nh...